Cognition Therapeutics, Inc. (CGTX)
1.205
+0.06
(+5.70%)
USD |
NASDAQ |
Jun 11, 16:00
1.205
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics EPS Diluted (Quarterly) : -0.0512 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0512 |
| December 31, 2025 | -0.0376 |
| September 30, 2025 | -0.0632 |
| June 30, 2025 | -0.1057 |
| March 31, 2025 | -0.1372 |
| December 31, 2024 | -0.1689 |
| September 30, 2024 | -0.2459 |
| June 30, 2024 | -0.1758 |
| March 31, 2024 | -0.2713 |
| December 31, 2023 | -0.2645 |
| September 30, 2023 | -0.2223 |
| June 30, 2023 | -0.1596 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2121 |
| December 31, 2022 | -0.1787 |
| September 30, 2022 | -0.2877 |
| June 30, 2022 | -0.2546 |
| March 31, 2022 | -0.1711 |
| December 31, 2021 | -0.3394 |
| September 30, 2021 | -0.2255 |
| June 30, 2021 | -0.129 |
| March 31, 2021 | -0.0413 |
| September 30, 2020 | -0.1296 |
| June 30, 2020 | -0.1243 |
| March 31, 2020 | -0.1622 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Verrica Pharmaceuticals, Inc. | -0.4544 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.57M |
| Total Expenses (Quarterly) | 4.57M |
| Enterprise Value | 71.10M |
| Earnings Yield | -21.39% |
| Normalized Earnings Yield | -21.39 |